An Oncolytic Virus–Delivered TGFβ Inhibitor Overcomes the Immunosuppressive Tumor Microenvironment

The authors generated αPD-1 resistant variants of the murine HNSCC model MEER. While entirely αPD-1 resistant, these tumors regressed after single dose of oncolytic vaccinia virus .